FDA introduces TEMPO model to complement CMS ACCESS model
The Food and Drug Administration plans to select about 40 devices not yet cleared by the agency to receive special agency discretion to participate in the new chronic care Advancing…
- Mon. Jul 13th, 2026
Connecting the World, Technology in Time